UCP2 and Alzheimer disease: It is possible than an elevation in UCP2 content would have masked an increase in MMP in the AD-A subgroup; thus, further research is needed to clarify whether ETC complexes are overactive in this subgroup and whether such over-activity could drive an increase in ROS, MMP and UCP2 expression.